Skip to Content

Sonova Holding AG ADR PHBA

Morningstar Rating
$58.50 +1.00 (1.74%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PHBA is trading at a 117% premium.
Price
€58.47
Fair Value
€88.65
Uncertainty
Medium
1-Star Price
€67.94
5-Star Price
€85.19
Economic Moat
Mnhd
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PHBA is a good fit for your portfolio.

Trading Information

Previous Close Price
$57.50
Day Range
$58.5058.50
52-Week Range
$27.0276.00
Bid/Ask
$0.00 / $0.00
Market Cap
$17.44 Bil
Volume/Avg
0 /

Key Statistics

Price/Earnings (Normalized)
23.74
Price/Sales
4.56
Dividend Yield (Trailing)
1.60%
Dividend Yield (Forward)
1.47%
Total Yield
1.81%

Company Profile

Sonova is one of the world's manufacturers and distributors of hearing aids. The company is based in Switzerland and distributes its products in more than 100 countries through its internal sales team and independent retailers. It also sells cochlear implants through its advanced bionics subsidiary and recently acquired Sennheiser's consumer division to expand into audio technologies.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Large Core
Total Number of Employees
18,151

Competitors

Valuation

Metric
PHBA
GN
DEMANT
Price/Earnings (Normalized)
23.7429.1329.05
Price/Book Value
6.763.237.83
Price/Sales
4.561.743.27
Price/Cash Flow
21.0912.3416.94
Price/Earnings
PHBA
GN
DEMANT

Financial Strength

Metric
PHBA
GN
DEMANT
Quick Ratio
1.020.410.84
Current Ratio
1.450.591.37
Interest Coverage
23.783.996.91
Quick Ratio
PHBA
GN
DEMANT

Profitability

Metric
PHBA
GN
DEMANT
Return on Assets (Normalized)
10.91%1.71%8.40%
Return on Equity (Normalized)
26.88%5.73%28.27%
Return on Invested Capital (Normalized)
17.63%3.07%12.19%
Return on Assets
PHBA
GN
DEMANT
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesKkcvftbdHgqghn$181.3 Bil
SYK
Stryker CorpHkgprtrstBzdb$127.8 Bil
BSX
Boston Scientific CorpRtgpznfqcQtcrml$111.2 Bil
MDT
Medtronic PLCDmydjtcpStzhp$107.9 Bil
EW
Edwards Lifesciences CorpGyqmpqdtYjgnxg$53.0 Bil
DXCM
DexCom IncHztkxrnltkHvvv$50.4 Bil
PHG
Koninklijke Philips NV ADRJtwvdclgFhtqzy$25.3 Bil
ZBH
Zimmer Biomet Holdings IncYpfdpbbrhKfkt$23.9 Bil
ALGN
Align Technology IncDnnvvzrbKqsppl$19.2 Bil
PODD
Insulet CorpMbjykzhyrHtmnpx$12.7 Bil

Sponsor Center